On August 5, 2014, Genomatica announced that it will be focusing on developing complete process technologies for the biobased production of major nylon intermediates -- including hexamethylenediamine, caprolactam, and adipic acid (HMD, CPL, and ADA). A copy of Genomatica's press release on this announcement is available online.